Dan L. O'Korn

Dan O’Korn's practice focuses on the business transactions important to pharmaceutical and biotech companies, including licensing and commercial transactions, FDA-related regulatory matters, asset acquisitions and divestitures, supply agreements, product development agreements and strategic alliances. Dan previously served as outside counsel to life science companies and in in-house counsel roles for Eli Lilly and Company, AAIPharma, Inc., Xanodyne Pharmaceuticals, Inc., and Xcellerex, Inc.

Please note: Use of any email address on this site does not create an attorney-client relationship. Additionally, any information included in your email will not be considered confidential or privileged without prior authorization.

By selecting "accept" below, you are confirming that you have read, understand and agree with these statements.

Accept

Recognition, Affiliations & Memberships

  • North Carolina State Bar
  • Pinnacle Award (Eli Lilly)
  • Corporate Business Development Award of Merit (Eli Lilly)
  • Sourcing Innovation Energizer Award (Eli Lilly)
  • American Jurisprudence Award

Education

  • J.D., summa cum laude, Indiana University School of Law
  • B.A., Wabash College

Admissions

  • North Carolina
  • Indiana